| [1] |
Reintam BA, Jakob SM, Starkopf J. Gastrointestinal failure in the ICU[J]. Curr Opin Crit Care, 2016, 22(2):128.
|
| [2] |
Mateer SW, Cardona J, Marks E, et al. Ex vivo intestinal sacs to assess mucosal permeability in models of gastrointestinal disease[J]. J Vis Exp, 2016, (108):e53250.
|
| [3] |
杨定周，周其全，李素芝，等.高原缺氧致大鼠肠黏膜屏障功能损伤及谷氨酰胺的保护作用观察[J].解放军医学杂志，2011，36（3）：301-306.
|
| [4] |
Youssef NN, Mezoff AG, Carter BA, et al. Medical update and potential advances in the treatment of pediatric intestinal failure[J]. Curr Gastroenterol Rep, 2012, 14(3):243-252.
|
| [5] |
王晖.早期肠内营养对肠黏膜屏障的影响[D].天津：天津医科大学，2011.
|
| [6] |
丁丽丽，朱明炜.口服营养补充疗法在老年患者中的应用[J].中国食物与营养，2017，23（9）：69-72.
|
| [7] |
Su F, Patel GB, Hu S, et al. Induction of mucosal immunity through systemic immunization: Phantom or reality[J]? Human Vaccin Immunother, 2016, 12(4):1070-1079.
|
| [8] |
Tlaskalováhogenová H, Kozáková H, Hudcovic T, et al. The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases[J]. Cell Mol Immunol, 2011, 8(2):110.
|
| [9] |
Youssef NN, Mezoff AG, Carter BA, et al. Medical update and potential advances in the treatment of pediatric intestinal failure[J]. Curr Gastroenterol Rep, 2012, 14(3):243-252.
|
| [10] |
黎介寿.重视胃肠道功能障碍患者的营养问题[J].中华胃肠外科杂志，2012，15（5）：423-425.
|
| [11] |
Dong L, Zhong X, Zhang L, et al. Impaired intestinal mucosal immunity is associated with the imbalance of T lymphocyte sub-populations in intrauterine growth-restricted neonatal piglets[J]. Immunobiology, 2015, 220(6):775-781.
|
| [12] |
Chen M, Yang T, Meng X, et al. Azithromycin attenuates cigarette smoke extract-induced oxidative stress injury in human alveolar epithelial cells[J]. Mol Med Rep, 2015, 11(5):3414-3422.
|
| [13] |
Wischmeyer PE. Tailoring nutrition therapy to illness and recovery[J]. Critical Care, 2017, 21(Suppl 3):316.
|
| [14] |
Andonegui G, Krein PM, Mowat C, et al. Enhanced production of IGF-I in the lungs of fibroproliferative ARDS patients[J]. Physiol Rep, 2015, 2(11):339-342.
|
| [15] |
Matsumoto T. [Bacterial translocation][J]. Jpn J Clin Med, 2017, 65 Suppl 2:73-77.
|
| [16] |
Vitetta L, Briskey D, Alford H, et al. Probiotics, prebiotics and the gastrointestinal tract in health and disease[J]. Inflammopharmacology, 2014, 22(3):135-54.
|
| [17] |
武焱旻，杨青茹，张敬浩.重症肺炎肠黏膜屏障与APACHEⅡ评分及血清D-乳酸水平的关系[J]. 滨州医学院学报，2013，36（5）：342-344.
|
| [18] |
戴梅，蒙烨，黄永坤，等.支气管肺炎患儿的肠黏膜屏障测定及临床意义[J].昆明医科大学学报，2013，34（6）：71-74.
|
| [19] |
来薛，赵丹，俞庆声，等.中医药对呼吸道黏膜免疫影响的研究进展[J].中华中医医药杂志，2013，28（1）：164-167.
|
| [20] |
张琳.肠道微生态环境与儿童过敏性疾病的关系以及参芪健脾方对肠黏膜屏障功能修复和免疫功能调整的研究[D].石家庄：河北医科大学，2011.
|
| [21] |
Gauthier M, Ray A, Wenzel SE. Evolving concepts of asthma[J]. Am J Respir Crit Care Med, 2015, 192(6):660-668.
|
| [22] |
王宗润.艰难梭状芽孢杆菌在喘息儿童粪便中的变化及免疫相关性的探讨[D].长春：吉林大学，2015.
|
| [23] |
李海玲，李凡.GOLD 2017更新要点解读及其对中国慢性阻塞性肺疾病分级诊疗的启示[J].中国全科医学，2017，20（18）：2171-2175.
|
| [24] |
Montesd OM, Pérez-Padilla R. Global Initiative for Chronic Obstructive Lung Disease (GOLD)-2017: the alat perspective[J]. Arch Bronconeumol, 2017, 53(7):87-88.
|
| [25] |
温燕，李小美，李家树.老年慢性阻塞性肺疾病急性加重患者肠黏膜屏障功能变化的临床研究[J].实用医学杂志，2013，29（16）：2600-2602.
|
| [26] |
王煦.慢性阻塞性肺疾病并发呼吸衰竭早期肠内营养支持[J].中国药物与临床，2014，14（4）：499-501.
|
| [27] |
Kim S, Cheoi KS, Lee HJ, et al. Safety and patient satisfaction of early diet after endoscopic submucosal dissection for gastric epithelial neoplasia: a prospective, randomized study[J]. Surg Endosc, 2014, 28(4):1321-1329.
|
| [28] |
孙锦涛，徐兴祥.特发性肺纤维化发病机制及药物治疗的研究进展[J].中华肺部疾病杂志（电子版），2015，8（2）：82-87.
|
| [29] |
Rafii R, Juarez MM, Albertson TE, et al. A review of current and novel therapies for idiopathic pulmonary fibrosis[J]. J Thoracic Dis, 2013, 5(1):48-73.
|
| [30] |
陈兰英.早期肠内营养对特发性肺间质纤维化治疗后肠功能障碍的影响[J].职业与健康，2014，30（20）：3003-3005.
|
| [31] |
范晓蕾.肠脂肪酸结合蛋白和D-乳酸在肺炎合并胃肠功能损伤患儿血清中的变化及意义[D].郑州：郑州大学，2016.
|